Published on 31 Jan 2024 on Simply Wall St. via Yahoo Finance
Key Insights
Institutions' substantial holdings in Atara Biotherapeutics implies that they have significant influence over the company's share priceThe top 8 shareholders own 52% of the company Recent purchases by insiders
To get a sense of who is truly in control of Atara Biotherapeutics, Inc. (NASDAQ:ATRA), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are institutions with 61% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.